Literature DB >> 20358426

Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.

Sabrina Kellouche1, Julien Fernandes, Johanne Leroy-Dudal, Olivier Gallet, Soizic Dutoit, Laurent Poulain, Franck Carreiras.   

Abstract

Ovarian cancer progression is frequently associated with the development of malignant ascites. Multicellular aggregates of carcinoma cells (spheroids) found within ascites are thought to be able to promote peritoneal carcinomatosis. We have previously demonstrated the involvement of the vitronectin/alphav integrin adhesive system in the dissemination of ovarian cancer cells and continue to investigate the influence of these molecules by studying their role(s) in spheroid behavior. The aim of this study was to generate ovarian cancer multicellular aggregates and to focus on the role of vitronectin and alphav integrins in their initiation. IGROV1 cancer cells cultured in the absence of adhesive substratum formed multicellular aggregates comparable to spheroids. After 21 days, a fraction of the cells within clusters remained viable and proliferated recurrently. Within the multicellular aggregates, vitronectin and alphav integrins were co-localized at intercellular sites, suggesting their involvement in cell-cell interactions. Initial formation of IGROV1 aggregates was inhibited using anti-vitronectin and anti-alphav integrin blocking antibodies or the cyclic peptide cRGDfV. Vitronectin expression persisted during cluster disaggregation on fibronectin. These results demonstrate the ability of IGROV1 cells to generate multicellular aggregates and point to a contributory role for the vitronectin/alphav integrin system in the initial step of this process. These events could represent a prerequisite for further dissemination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20358426     DOI: 10.1007/s13277-010-0017-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.

Authors:  R C Casey; K M Burleson; K M Skubitz; S E Pambuccian; T R Oegema; L E Ruff; A P Skubitz
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.

Authors:  B Davidson; A Berner; J M Nesland; B Risberg; H S Berner; C G Tropè; G B Kristensen; M Bryne; V Ann Florenes
Journal:  J Pathol       Date:  2000-12       Impact factor: 7.996

4.  Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma.

Authors:  F Carreiras; Y Denoux; C Staedel; M Lehmann; F Sichel; P Gauduchon
Journal:  Gynecol Oncol       Date:  1996-08       Impact factor: 5.482

5.  A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.

Authors:  Stephan Hoffmann; Shikun He; Manlin Jin; Marianne Ehren; Peter Wiedemann; Stephen J Ryan; David R Hinton
Journal:  BMC Ophthalmol       Date:  2005-06-29       Impact factor: 2.209

6.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Authors:  Hilary A Kenny; Swayamjot Kaur; Lisa M Coussens; Ernst Lengyel
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

7.  Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.

Authors:  Loraine Heyman; Sabrina Kellouche; Julien Fernandes; Soizic Dutoit; Laurent Poulain; Franck Carreiras
Journal:  Tumour Biol       Date:  2008-09-09

8.  AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.

Authors:  Ben Davidson; Iris Goldberg; Reuven Reich; Liora Tell; Hiep Phuc Dong; Claes G Trope'; Bjørn Risberg; Juri Kopolovic
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

Review 9.  Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

Authors:  Kristy Shield; M Leigh Ackland; Nuzhat Ahmed; Gregory E Rice
Journal:  Gynecol Oncol       Date:  2009-01-10       Impact factor: 5.482

10.  Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.

Authors:  Sandra Hapke; Horst Kessler; Birgit Luber; Anke Benge; Peter Hutzler; Heinz Höfler; Manfred Schmitt; Ute Reuning
Journal:  Biol Chem       Date:  2003-07       Impact factor: 3.915

View more
  8 in total

Review 1.  The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.

Authors:  Sabrina J Ritch; Carlos M Telleria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

2.  Vitronectin significantly influences prognosis in osteosarcoma.

Authors:  Kai Shi; Rui-Long Lan; Xuan Tao; Chao-Yang Wu; Hai-Feng Hong; Jian-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins.

Authors:  L Carduner; J Leroy-Dudal; C R Picot; O Gallet; F Carreiras; S Kellouche
Journal:  Clin Exp Metastasis       Date:  2014-06-20       Impact factor: 5.150

4.  PAI-1: An Integrator of Cell Signaling and Migration.

Authors:  Ralf-Peter Czekay; Cynthia E Wilkins-Port; Stephen P Higgins; Jennifer Freytag; Jessica M Overstreet; R Matthew Klein; Craig E Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  Int J Cell Biol       Date:  2011-08-03

5.  Hydrogel Microwell Arrays Allow the Assessment of Protease-Associated Enhancement of Cancer Cell Aggregation and Survival.

Authors:  Daniela Loessner; Stefan Kobel; Judith A Clements; Matthias P Lutolf; Dietmar W Hutmacher
Journal:  Microarrays (Basel)       Date:  2013-08-22

Review 6.  Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review.

Authors:  Dolly Dhaliwal; Trevor G Shepherd
Journal:  Clin Exp Metastasis       Date:  2021-11-25       Impact factor: 5.150

7.  Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells.

Authors:  Anaïs Wambecke; Carine Laurent-Issartel; Johanne Leroy-Dudal; Florence Giffard; Fanny Cosson; Nadège Lubin-Germain; Jacques Uziel; Sabrina Kellouche; Franck Carreiras
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

8.  Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells.

Authors:  Romana Dolinschek; Julia Hingerl; Anke Benge; Christian Zafiu; Elisabeth Schüren; Eva-Kathrin Ehmoser; Daniela Lössner; Ute Reuning
Journal:  Mol Oncol       Date:  2020-12-01       Impact factor: 7.449

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.